Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tookman LA"'
Autor:
Cheng Z; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., Ennis DP; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Lu B; Department of Cell and Developmental Biology, University College London, London, UK., Mirza HB; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Sokota C; Department of Cellular Pathology, Imperial College Healthcare NHS Trust, London, UK., Kaur B; Department of Cellular Pathology, Imperial College Healthcare NHS Trust, London, UK., Singh N; Department of Pathology, Barts Healthcare NHS Trust, London, UK., Le Saux O; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Russo G; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Giannone G; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Tookman LA; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Krell J; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK., Barnes C; Department of Cell and Developmental Biology, University College London, London, UK., McDermott J; Department of Cellular Pathology, Imperial College Healthcare NHS Trust, London, UK., McNeish IA; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
Publikováno v:
The Journal of pathology [J Pathol] 2024 Sep; Vol. 264 (1), pp. 42-54. Date of Electronic Publication: 2024 Jul 02.
Autor:
Cheng Z; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom., Mirza H; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom., Ennis DP; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom., Smith P; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Morrill Gavarró L; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Sokota C; Department of Cellular Pathology, Imperial College Healthcare NHS Trust, London, United Kingdom., Giannone G; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.; Department of Oncology, University of Turin, Turin, Italy., Goranova T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Bradley T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Piskorz A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Lockley M; Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Kaur B; Department of Cellular Pathology, Imperial College Healthcare NHS Trust, London, United Kingdom., Singh N; Department of Pathology, Barts Healthcare NHS Trust, London, United Kingdom., Tookman LA; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom., Krell J; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom., McDermott J; Department of Pathology, University College London Hospital NHS Trust, London, United Kingdom., Macintyre G; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Markowetz F; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., McNeish IA; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jul 01; Vol. 28 (13), pp. 2911-2922.
Autor:
Walton J; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Blagih J; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Ennis D; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Leung E; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Dowson S; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Farquharson M; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Tookman LA; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Orange C; Department of Pathology, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Athineos D; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Mason S; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Stevenson D; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Blyth K; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Strathdee D; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Balkwill FR; Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Vousden K; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Lockley M; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., McNeish IA; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom. iain.mcneish@glasgow.ac.uk.
Publikováno v:
Cancer research [Cancer Res] 2016 Oct 15; Vol. 76 (20), pp. 6118-6129. Date of Electronic Publication: 2016 Aug 16.
Autor:
Tookman LA; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Browne AK; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Connell CM; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Bridge G; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Ingemarsdotter CK; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Dowson S; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Shibata A; Advanced Scientific Research Leaders Development Unit, Gunma University, Maebashi, Gunma, Japan., Lockley M; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Martin SA; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., McNeish IA; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom. Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. Iain.mcneish@glasgow.ac.uk.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2016 Jan; Vol. 14 (1), pp. 44-55. Date of Electronic Publication: 2015 Oct 09.
Autor:
Browne A; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom., Tookman LA; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom., Ingemarsdotter CK; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom., Bouwman RD; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom., Pirlo K; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom., Wang Y; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom., McNeish IA; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom. Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Lockley M; Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, United Kingdom. m.lockley@qmul.ac.uk.
Publikováno v:
Cancer research [Cancer Res] 2015 Jul 15; Vol. 75 (14), pp. 2811-21. Date of Electronic Publication: 2015 May 14.
Autor:
Ingemarsdotter CK; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Tookman LA; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Browne A; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Pirlo K; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Cutts R; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Chelela C; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Khurrum KF; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Leung EY; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Dowson S; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Webber L; Cancer Research UK and UCL Clinical Trials Centre, London, UK., Khan I; Cancer Research UK and UCL Clinical Trials Centre, London, UK., Ennis D; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Syed N; Division of Brain Sciences, Faculty of Medicine, Imperial College, London, UK., Crook TR; Dundee Cancer Centre, University of Dundee, Ninewells Hospital, Dundee, UK., Brenton JD; Cancer Research UK Cambridge Institute, Cambridge, UK., Lockley M; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., McNeish IA; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. Electronic address: iain.mcneish@glasgow.ac.uk.
Publikováno v:
Molecular oncology [Mol Oncol] 2015 Apr; Vol. 9 (4), pp. 791-805. Date of Electronic Publication: 2014 Dec 29.
Autor:
Young AM; Barts Cancer Institute, Queen Mary University of London, London, UK., Archibald KM, Tookman LA, Pool A, Dudek K, Jones C, Williams SL, Pirlo KJ, Willis AE, Lockley M, McNeish IA
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2012 Sep; Vol. 20 (9), pp. 1676-88. Date of Electronic Publication: 2012 Jun 26.
Autor:
Connell CM; Centre for Molecular Oncology and Imaging, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Shibata A, Tookman LA, Archibald KM, Flak MB, Pirlo KJ, Lockley M, Wheatley SP, McNeish IA
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2011 Apr; Vol. 121 (4), pp. 1283-97. Date of Electronic Publication: 2011 Mar 07.